Article info
PDFReview
Vagus nerve stimulation for drug-resistant epilepsy
- Correspondence to Dr Laura Pérez-Carbonell, Sleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK; laurapcarbonell{at}gmail.com
Citation
Vagus nerve stimulation for drug-resistant epilepsy
Publication history
- Accepted November 20, 2019
- First published December 31, 2019.
Online issue publication
June 02, 2020
Article Versions
- Previous version (2 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Comparing neurostimulation technologies in refractory focal-onset epilepsy
- Vagus nerve stimulation for epilepsy
- Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry
- Sudden unexpected death in epilepsy: basic mechanisms and clinical implications for prevention
- Perianaesthetic management on a child with Lennox-Gastaut Syndrome for vagus nerve stimulation (VNS) placement
- Vagus nerve stimulation: predictors of seizure freedom
- Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS): a prospective observational protocol to identify biomarkers of seizure response in children and youth
- Epilepsy surgery
- Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up
- Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy